RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Cardiovascular and cerebrovascular events among patients receiving omalizumab
Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials
Iribarren, C., Rothman, K. J., Bradley, M. S., Carrigan, G., Eisner, M. D., & Chen, H. (2017). Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials. Journal of Allergy and Clinical Immunology, 139(5), 1678-1680. https://doi.org/10.1016/j.jaci.2016.12.953
